PFA
CVAC

Paradigm Financial Advisors’s CureVac CVAC Stock Holding History

Paradigm Financial Advisors’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$464K Sell
13,535
-474
-3% -$19.1K 0.1% 122
2021
Q3 		$765K Buy
+14,009
New +$844K 0.18% 94

Other funds holding CVAC

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Paradigm Financial Advisors's CVAC Position: Q4 2021 in Review

Paradigm Financial Advisors reduced its CureVac (CVAC) stake by 3.4% in Q4 2021, selling an estimated $19.1K and leaving 13,535 shares worth $464K. The position accounts for 0.1% of the portfolio, ranked #122.

Paradigm Financial Advisors first reported a position in CVAC in Q3 2021 and has held it in 2 quarters since. The position peaked at $765K in Q3 2021. 103 funds tracked by Wall St. Rank hold CVAC as of Q4 2021.

  • Paradigm Financial Advisors held 13,535 shares of CureVac worth $464K as of Q4 2021.
  • Paradigm Financial Advisors sold 474 CureVac shares in Q4 2021, an estimated $19.1K.
  • CureVac made up 0.1% of Paradigm Financial Advisors's portfolio in Q4 2021, its #122 holding.
  • Paradigm Financial Advisors first reported a position in CureVac in Q3 2021 and has held it in 2 quarters since.
  • Paradigm Financial Advisors's CureVac position peaked at $765K in Q3 2021.
  • 103 funds tracked by Wall St. Rank held CureVac as of Q4 2021.

Based on Paradigm Financial Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.